{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:07:09Z","timestamp":1791151629403,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1016\/s0145-2126(02)00272-2","type":"journal-article","created":{"date-parts":[[2003,3,25]],"date-time":"2003-03-25T15:53:30Z","timestamp":1048607610000},"page":"547-555","source":"Crossref","is-referenced-by-count":23,"title":["Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver"],"prefix":"10.1016","volume":"27","author":[{"given":"Petranel T","family":"Ferrao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie K","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(02)00272-2_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60508-8","article-title":"The Kit ligand, stem cell factor","volume":"55","author":"Galli","year":"1994","journal-title":"Adv. Immunol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1357-2725(99)00076-X","article-title":"The biology of stem cell factor and its receptor c-Kit","volume":"31","author":"Ashman","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","article-title":"Early signaling pathways activated by c-Kit in hematopoietic cells","volume":"31","author":"Linnekin","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB4","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-Kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"Buttner","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-Kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-Kit catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.01935.x","article-title":"Mastocytosis cells bearing a c-Kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis","volume":"108","author":"Dror","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/mp.53.4.188","article-title":"Detection of c-Kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia","volume":"53","author":"Sotlar","year":"2000","journal-title":"Mol. Pathol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0145-2126(01)00019-4","article-title":"A case of \u2018smouldering\u2019 mastocytosis with high mast cell burden, monoclonal myeloid cells, and c-Kit mutation Asp816Val","volume":"25","author":"Jordan","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10428190009057652","article-title":"Effects of mutant c-Kit in early myeloid cells","volume":"37","author":"Ashman","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","article-title":"c-Kit mutations in core binding factor leukemias","volume":"95","author":"Beghini","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/10428190109060342","article-title":"Activating mutations of c-Kit at codon 816 confer drug resistance in human leukemia cells","volume":"41","author":"Ning","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB14","first-page":"2345","article-title":"Specific c-Kit mutations in sinonasal natural killer\/T-cell lymphoma in China and Japan","volume":"60","author":"Hongyo","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB15","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)65419-3","article-title":"Activating c-kit gene mutations in human germ cell tumors","volume":"154","author":"Tian","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB16","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2120::AID-CNCR10>3.0.CO;2-C","article-title":"Clinical correlates of the presence of the Asp816Val c-Kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis","volume":"83","author":"Worobec","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1998.01072.x","article-title":"Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-Kit mutation Asp-816 to Val","volume":"103","author":"Sperr","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-Kit and occurrence of the c-Kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of c-Kit in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-Kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-Kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB22","first-page":"4297","article-title":"Effect of c-Kit mutation on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9440(10)65250-9","article-title":"Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas","volume":"154","author":"Lasota","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB24","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor","volume":"344","author":"Joensuu","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(01)06535-7","article-title":"Safety and efficacy of Imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study","volume":"358","author":"van Oosterom","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-Kit mutation causing human mastocytosis is resistant to STI571 and other Kit kinase inhibitors kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB27","first-page":"1105","article-title":"Juxtamembrane mutanat V560GKit is more sensitive to Imatinib (STI571) compared to wild-type c-Kit whereas the kinase domain mutant D816VKit is resistant","volume":"1","author":"Frost","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","article-title":"Constitutively activating mutations of c-Kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines","volume":"85","author":"Kitayama","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-Kit receptor tyrosine kinase","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB30","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood.V87.8.3117.bloodjournal8783117","article-title":"A point mutation in the catalytic domain of c-Kit induces growth factor independence, tumorigenicity, and differentiation of mast cells","volume":"87","author":"Piao","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB31","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1182\/blood.V90.11.4539","article-title":"Expression of constitutively activated human c-Kit in Myb transformed early myeloid cells leads to factor independence, histiocytic differentiation, and tumorigenicity","volume":"90","author":"Ferrao","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000236870","article-title":"Substitution of an aspartic acid results in constitutive activation of c-Kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3","volume":"106","author":"Tsujimura","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB33","first-page":"189","article-title":"Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line","volume":"148","author":"Hashimoto","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB34","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1073\/pnas.93.25.14665","article-title":"Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1","volume":"93","author":"Piao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB35","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V98.5.1365","article-title":"Phosphatidylinositol-3-kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant","volume":"98","author":"Chian","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB36","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood.V97.11.3559","article-title":"Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells","volume":"97","author":"Ning","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB37","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand","volume":"6","author":"Yarden","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB38","unstructured":"Aylett GCSR, Caruana, G, Ashman, LK. Specificity and functional effects of mAb to c-Kit protein (SCF receptor). In: Schlossman SFBL, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, et al., editors. Leukocyte typing V\u2014white cell differentiation antigens. Oxford: Oxford University Press; 1995. p. 1917\u201320."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB39","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1182\/blood.V82.9.2813.2813","article-title":"Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by Myb","volume":"82","author":"Gonda","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB40","first-page":"1631","article-title":"Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells","volume":"11","author":"Ferrao","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB41","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.4049\/jimmunol.149.7.2466","article-title":"Translation and granule localization of mouse mast cell protease-5. Immunodetection with specific antipeptide Ig","volume":"149","author":"McNeil","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB42","doi-asserted-by":"crossref","unstructured":"Karnovsky MJ, Roots LA. A direct coloring tricholine method for cholinesterases. J Histochem Cytochem 1964;12:219\u201321.","DOI":"10.1177\/12.3.219"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB43","first-page":"283","article-title":"Cytochemical identification of monocytes and granulocytes","volume":"55","author":"Yam","year":"1971","journal-title":"Am. J. Cytochem. Proc."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB44","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/MCB.13.4.2224","article-title":"Interspecies molecular chimeras of Kit help define the binding site of the stem cell factor","volume":"13","author":"Lev","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90301-T","article-title":"Primary structure and functional expression of rat and human stem cell factor DNAs","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB46","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1074\/jbc.271.7.3347","article-title":"Role of aspartic acid 814 in the function and expression of c-Kit receptor tyrosine kinase","volume":"271","author":"Moriyama","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB47","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem cell factor and hematopoiesis","volume":"90","author":"Broudy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB48","first-page":"1549","article-title":"Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain","volume":"6","author":"Hu","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V90.4.1471","article-title":"Expression of activated mutants of the human interleukin-3\/interleukin-5\/granulocyte-macrophage colony-stimulating factor receptor common beta subunit in primary hematopoietic cells induces factor-independent proliferation and differentiation","volume":"90","author":"McCormack","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB50","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood.V78.11.2854.2854","article-title":"Effect of c-Kit ligand on in vitro human megakaryopoiesis","volume":"78","author":"Briddell","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB51","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood.V85.7.1719.bloodjournal8571719","article-title":"Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin 11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro","volume":"85","author":"Broudy","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/icb.1987.27","article-title":"Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues","volume":"65","author":"Mayrhofer","year":"1987","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB53","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood.V80.12.3009.3009","article-title":"Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells","volume":"80","author":"Irani","year":"1992","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB54","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/Kit ligand in long-term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB55","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/MCB.17.9.5598","article-title":"Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21cip1","volume":"17","author":"Woods","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB56","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/MCB.17.9.5588","article-title":"High-intensity Raf signal causes cell cycle arrest mediated by p21cip1","volume":"17","author":"Sewing","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.onc.1201494","article-title":"Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement","volume":"16","author":"Caruana","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB58","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.V93.4.1319","article-title":"Activating mutation in the catalytic domain of c-Kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site","volume":"93","author":"Tsujimura","year":"1999","journal-title":"Blood."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002770050439","article-title":"Multilineage involvement and erythropoietin-\u201cindependent\u201d erythroid progenitor cells in a patient with systemic mastocytosis","volume":"77","author":"Afonja","year":"1998","journal-title":"Ann. Hematol."},{"key":"10.1016\/S0145-2126(02)00272-2_BIB60","first-page":"288","article-title":"Increased expression of c-Kit or its ligand steel factor is not a common feature of adult acute myeloid leukaemia","volume":"10","author":"Cole","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB61","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/304602a0","article-title":"Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture","volume":"304","author":"Ruley","year":"1983","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/304596a0","article-title":"Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes","volume":"304","author":"Land","year":"1983","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(02)00272-2_BIB63","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/22780","article-title":"Creation of human tumour cells with defined genetic elements","volume":"400","author":"Hahn","year":"1999","journal-title":"Nature"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212602002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212602002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T21:31:06Z","timestamp":1682458266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212602002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0145212602002722"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(02)00272-2","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}